Plain-English translation of NCT05295615 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a pilot study testing a device called the ECHS AD pulsed electromagnetic field treatment device for people with mild to moderate Alzheimer's disease. Participants will use the device at home three times daily for 15 minutes over four months. The study will measure whether this treatment helps preserve thinking and memory skills.
Currently, treatment options for Alzheimer's disease are limited. This trial is exploring whether electromagnetic field stimulation—a non-drug approach—might help slow cognitive decline and offer patients a new tool to manage their disease.
You likely qualify if…
You likely don't qualify if…
You will use the electromagnetic field treatment device at home three times each day for 15 minutes per session, continuing for 120 days (about four months). Your caregiver will help supervise and track your treatments. You'll complete cognitive testing (memory and thinking assessments) before starting treatment and again after the four months, with additional follow-up visits for nine months after the treatment period ends.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States